We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CoStar Group
CSGP
$12.3B
| $538K | ﹤0.01% |
9,000
-88,000
| -91% | -$5.14M |
|
|
PDS
1477
Precision Drilling
PDS
$974M
| $537K | ﹤0.01% |
19,245
+1,859
| +11% | +$42.7K |
|
|
AUD
1478
DELISTED
Audacy, Inc.
AUD
| $535K | ﹤0.01% |
+115,249
| New | +$482K |
|
|
DZSI
1479
DELISTED
DZS Inc. Common Stock
DZSI
| $531K | ﹤0.01% |
59,879
+27,200
| +83% | +$214K |
|
|
COWN
1480
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $530K | ﹤0.01% |
+33,662
| New | +$505K |
|
1481
Foster
FSTR
$432M
| $525K | ﹤0.01% |
27,105
| – | – |
|
|
CSLT
1482
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $519K | ﹤0.01% |
+390,036
| New | +$544K |
|
1483
Preformed Line Products
PLPC
$2.28B
| $517K | ﹤0.01% |
8,563
-500
| -6% | -$31.1K |
|
|
CTG
1484
DELISTED
Computer Task Group, Inc.
CTG
| $515K | ﹤0.01% |
99,372
| – | – |
|
|
SINA
1485
DELISTED
Sina Corp
SINA
| $515K | ﹤0.01% |
+12,900
| New | +$495K |
|
1486
MaxLinear
MXL
$6.8B
| $512K | ﹤0.01% |
24,147
-3,353
| -12% | -$69.6K |
|
|
AFMD
1487
DELISTED
Affimed
AFMD
| $499K | ﹤0.01% |
18,219
+6,948
| +62% | +$186K |
|
|
VCRA
1488
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $499K | ﹤0.01% |
+24,029
| New | +$527K |
|
1489
ASE Group
ASX
$82.2B
| $498K | ﹤0.01% |
+89,507
| New | +$459K |
|
|
SUP
1490
DELISTED
Superior Industries International
SUP
| $497K | ﹤0.01% |
134,598
-27,843
| -17% | -$84.7K |
|
1491
Enanta Pharmaceuticals
ENTA
$400M
| $494K | ﹤0.01% |
+8,000
| New | +$496K |
|
|
HPR
1492
DELISTED
HighPoint Resources Corporation
HPR
| $494K | ﹤0.01% |
+5,852
| New | +$381K |
|
|
PRGX
1493
DELISTED
PRGX Global, Inc.
PRGX
| $493K | ﹤0.01% |
100,214
-18,772
| -16% | -$91K |
|
1494
Acacia Research
ACTG
$470M
| $488K | ﹤0.01% |
183,568
-115,931
| -39% | -$318K |
|
1495
Natural Resource Partners
NRP
$1.42B
| $487K | ﹤0.01% |
24,193
-37,780
| -61% | -$874K |
|
1496
Johnson Outdoors
JOUT
$505M
| $483K | ﹤0.01% |
+6,300
| New | +$412K |
|
1497
Alamo Group
ALG
$2.05B
| $477K | ﹤0.01% |
+3,800
| New | +$444K |
|
1498
Merchants Bancorp
MBIN
$2.49B
| $476K | ﹤0.01% |
+36,233
| New | +$423K |
|
|
EFC
1499
Ellington Financial
EFC
$1.71B
| $473K | ﹤0.01% |
+25,800
| New | +$471K |
|
1500
Greenlight Captial
GLRE
$506M
| $469K | ﹤0.01% |
46,415
+10,817
| +30% | +$112K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.